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Introduction
Caveolae, flask-shaped invaginations of the plasma membrane,
are a striking feature of many mammalian cells. Caveolae are
defined by their morphology and by the presence of integral
membrane proteins, called caveolins (Parton et al., 2006).
Caveolins and caveolae have been linked to diseases such as cancer
(Hayashi et al., 2001; Koleske et al., 1995) and muscular dystrophy
(Galbiati et al., 1999; Minetti et al., 1998; Woodman et al., 2004),
highlighting the importance of understanding the relationship
between caveolae morphology and their functions. Caveolins are
fundamental to caveola formation in mammalian cells (Parton et
al., 2006). Caveolae can be generated de novo by the transient
expression of caveolin-1 (Cav1) (Fra et al., 1995) or the muscle
specific isoform caveolin-3 (Cav3) (Capozza et al., 2005), and
are regulated by a cytoplasmic protein PTRF (polymerase I and
transcript release factor)-Cavin (Hill et al., 2008; Liu and Pilch,
2008). Recently the coexpression of flotillin-1 (also known as
FLOT1, reggie-2) and flotillin-2 (also known as FLOT2, reggie-
1) has also been reported to induce the formation of caveola-like
structures (Frick et al., 2007). Caveolin-2 (Cav2) has an
overlapping expression pattern with Cav1 in most tissues (Scherer
et al., 1996) and when coexpressed, is localised to caveolae. When
Cav2 is expressed without Cav1 or Cav3 it is localised to the Golgi
complex (Mora et al., 1999). This suggests Cav2 has a regulatory
role in caveola formation and dynamics (Sowa et al., 2003). Cav2
may have an additional role distinct from caveolae formation, as
shown by the fact that Cav2-null mice form caveolae, but display
evidence of severe pulmonary dysfunction (Razani et al., 2002b).
Cav1 binds directly to cholesterol (Murata et al., 1995) and
cholesterol is required for caveola formation or stability, because
cholesterol depletion disrupts caveolar structure (Rothberg et al.,
1992). However, the molecular details of caveola formation
induced through caveolin-membrane interactions are still
unknown.
All caveolin family members are predicted to have a 33 amino
acid intramembrane domain with both N- and C-termini facing
the cytoplasm (Parton et al., 2006). The C-terminus is
palmitoylated during transit through the secretory pathway
(Dietzen et al., 1995). Cav1 and Cav3 can form high-molecular-
weight complexes through homo- and hetero-oligomerisation
(Monier et al., 1995; Tang et al., 1996) that become enriched in
low-density fractions following density gradient centrifugation
after treatment with specific detergents (Kurzchalia et al., 1992).
A large number of deletion, truncation and amino-acid substitution
mutants of Cav1 and Cav3 that are retained within the Golgi
complex also have an impaired ability to oligomerise and/or
become detergent insoluble (Luetterforst et al., 1999; Machleidt
et al., 2000; Ren et al., 2004). These include a number of Cav3
mutations that are associated with muscle diseases (Galbiati et
al., 1999; Woodman et al., 2004). This has led to the hypothesis
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that Cav1 or Cav3 must adopt the correct protein conformation
to exit the Golgi complex and that this conformation is very
sensitive to alterations in the amino acid sequence (Ren et al.,
2004).
Examination of systems from across the diversity of eukaryotes
has provided important insights into numerous aspects of membrane
traffic. Sequence homology searches have suggested that caveolins
appeared relatively late in eukaryotic evolution and are specific to
the metazoan (vertebrate and invertebrate animal) branch of
opisthokonta but absent from the fungi (yeast) branch, as well as
from plants and non-metazoan parasites (Field et al., 2007). Among
metazoans, caveolins are evolutionarily conserved from humans to
nematodes (Spisni et al., 2005; Tang et al., 1997) but apparently
absent from Drosophila melanogaster. It is also unclear when
caveolins acquired the property of caveola formation during
metazoan evolution. Caveolin function has been studied in three
non-mammalian systems. In Danio rerio (zebrafish), both caveolins
and putative caveolae structures have been described (Nixon et al.,
2005). In the adult Xenopus laevis, caveolin expression has been
detected in lung, muscle and fat tissues, similar to its expression
pattern in mammals (Razani et al., 2002a). In C. elegans there are
two isoforms of caveolin but only C. elegans Cav1 (CeCav1) has
been studied. CeCav1 was not ubiquitously expressed in the adult
hermaphrodite nematode, but was present within the gonad arm
(Scheel et al., 1999) and both neurons and body wall muscles, where
it was suggested to have a role at the neuromuscular junction (Parker
et al., 2007). CeCav1 was also localised to the plasma membrane
of cells within the early embryo where it was endocytosed in a
clathrin-dependent manner (Sato et al., 2006). However, no study
has directly addressed whether CeCav1 can form caveolae.
We have established a system to analyse de novo formation of
caveolae in mammalian cells lacking caveolae and in combination
with phylogenetic analysis we have studied the evolution of
caveolins and caveolae. We show that the ability of caveolin to form
caveolae has not been conserved in C. elegans but has been
conserved in another branch of invertebrate caveolins (i.e. that of
Apis mellifera, honeybee). Furthermore, genomic comparison of
caveolins showed a pattern of gene duplication and loss in both the
vertebrate and invertebrate lineages. CeCav1 was used as a scaffold
to create hybrid constructs between different caveolins in order to
analyse the importance of specific domains of mammalian caveolin
in caveola formation. In combination with a range of truncation
and point mutants we have identified previously uncharacterised
domains in mammalian Cav1 that are fundamental for caveola
formation. We also demonstrated that, in cells that lack Cav1,
flotillin-1 and flotillin-2 could not form caveola-like structures.
These results lead to new insights into the functional evolution of
caveolins and the development of a new model for caveola
formation.
Results
Evolutionary analysis of caveolins and caveolae formation in
metazoans
Cav1 and Cav3 are essential for caveola formation in mammalian
cells but the role of caveolins in other eukaryotes is less clear. To
increase the understanding of caveolin biology, we performed an
extensive database search for caveolin sequences and identified new
sequences in expressed sequence tag (EST) and genomic databases
(supplementary material Table S1). The caveolin sequences we
gathered in these searches all belong to metazoans and none were
observed in the genome of the choanoflagellate Monosiga
brevicollis, an observation consistent with the prediction that
caveola formation arose in the animal lineage (Field et al., 2007).
A considerable degree of conservation was observed among all
sequences analysed (supplementary material Fig. S1), with the most
divergent regions in the distal N- and C-termini.
To establish the pattern of diversification of the caveolins in
metazoans we performed a phylogenetic analysis using the most
conserved region of caveolins – equivalent to amino acids R54 to
P158 in human CAV1 (HsCav1) – approximately half of the protein
(supplementary material Fig. S1). Four different phylogenetic
methods were used in this study (Bayesian interference, maximum-
likelihood (ML), neighbour-joining (NJ), parsimony) and they all
indicate that two ancient groups of caveolin can be distinguished:
the ‘classical’ caveolin group, which includes all known vertebrate
caveolins, and a ‘caveolin-like’ group which includes a demosponge,
an annelide and three chordate sequences (Fig. 1). In the classical
caveolin group the vertebrate sequences fall into three well-
supported groupings, a Cav1-Cav3 group, a Cav2-Cav2-related-
sequences (Cav2R) group and the CavY clade. The latter group is
the only of these three groups to include non-vertebrate sequences
and comprises two tunicate sequences (CavY minimum group, Fig.
1).
The relationships of the protostomian (worms, arthropods and
molluscs) and non-bilaterian (sea anemones and the placozoan
Trichoplax) caveolin sequences with the three groups of vertebrate
sequences are not fully resolved. Indeed, whereas protostome
sequences form three groups (G1-G3, Fig. 1) only one (G1) is related
to vertebrate sequences, a relationship supported by two of the four
phylogenetic methods (‘CavY extended’; Fig. 1). Interestingly, the
NJ analysis suggested that G1 and G3 form a single group (interior
branch test support: 98). To test whether the two nematode
sequences forming the G3 group are divergent members of the G1
group and whether this divergence contributes to the partial support
for the G1 and ‘CavY extended’ groups, we repeated the
phylogenetic analysis without these two sequences. The new
analysis shows an increased support for the G1 and CavY extended
groups (Fig. 1), reinforcing the possibility that the G1 and ‘CavY
minimum’ groups are related. If so, the duplication between CavY
and the other two vertebrate groups (Cav1-Cav3, Cav2-Cav2R)
preceded the protostome-deuterostome split. Such an ancient split
is also seen for the two main protostome groups because G1 and
G2 both contain arthropod sequences, but the arthropod G2
sequences are more related to the nematode G2 sequences than to
the arthropod G1 sequences. This indicates that the G1-G2
separation took place before the nematode-arthropod split. To
account for the uncertainty in the relationships between the
vertebrate and non-vertebrate sequences we have used suffixes (-a,
-b, etc.) to name the duplicated caveolin sequences in non-
vertebrates. In view of this new analysis it is misleading to describe
C. elegans caveolins as Cav1 or Cav2; therefore, CeCav1, for
example, will here be referred to as CeCav-a (C. elegans Cav-a).
The phylogenetic analysis suggests that the duplications between
Cav1 and Cav3 and between Cav2 and Cav2R both occurred in
vertebrates. In human, pufferfish and Xenopus tropicalis genomes,
Cav1 and Cav2 are located next to each other, whereas Cav3 is on
another chromosome (Fig. 2A). The presence of a Cav2R gene in
bony fishes and frogs next to the Cav3 orthologue suggests that the
Cav1-Cav2 and the Cav3-Cav2R genomic segments originate from
a single en-bloc duplication in a vertebrate ancestor. This then raises
the question of when the duplication between the ancestor of Cav1
and Cav3 (CavX) and the ancestor of Cav2 and Cav2R (CavZ)
Journal of Cell Science 121 (12)
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
2077Biogenesis of caveolae
occurred, and whether this can be timed relative to the emergence
of CavY. Whereas the amphibian CavY has an ortholog in tunicates,
two divergent sequences with no clear vertebrate orthologs are
present in the genomes of Ciona intestinalis and Ciona savignyi
(Cav-a and Cav-b) (Fig. 1). Interestingly their genes
are localised on the same genomic segment and in
the same transcription orientation (Fig. 2A), which
is reminiscent of Cav1-Cav2 and Cav3-Cav2R in
vertebrates. This is consistent with a model where
the CavX-CavZ duplication took place before the
split between vertebrates and urochordates, so that
tunicates would possess an equivalent for both
Cav1-Cav3, and Cav2-Cav2R (Fig. 2B). Although
it is not possible to time the duplication that gave
rise to CavY relative to that producing CavX and
CavZ, CavY clearly arose before chordates split into
urochordates and vertebrates (CavY minimum, Fig.
1) and probably before the split between
protostomes and deuterostomes (‘CavY extended’,
Fig. 1). 
It is clear from the phylogenetic analysis that the
ancestral caveolin gene has undergone ancient
duplications. This plasticity of the caveolin family
can be seen when the caveolin gene content is
compared in detail within the different taxonomic
groups. It then becomes evident that there were a
large number of lineage-specific duplications and
also gene loss. For example, in addition to the
vertebrate-specific Cav1-Cav3, and Cav2-Cav2R
duplications, several vertebrate species further
expanded their caveolin gene content and, whereas
humans only have three caveolins, bony fishes can
have up to five caveolin genes (zebrafish Cav1,
Cav2, Cav2R1, Cav2R2 and Cav3) and amphibians
up to six (X. tropicalis Cav1, Cav2, Cav2R, Cav3-1,
Cav3-2 and CavY). Such expansions are also seen
in protostomes, particularly in molluscs, because
Lottia gigantean, for example, possesses three to five genes that
belong to the G1 group. Genetic loss is also extensive. With the
exception of the amphibians, most vertebrates lack a CavY
descendant, Cav2R was lost in placental mammals, the G1 group
Fig. 1. Evolutionary conservation of caveolins. Caveolin
phylogeny. Phylogenetic analyses were performed with
Bayesian interference, ML, NJ and parsimony methods
from the alignment of caveolin sequences to R54 to P158 in
HsCav1 to P158. The ML tree topology was used for the
display (with a midpoint rooting) and the node support is
given in the following order (from top to bottom): Bayesian
(posterior probability, PP), ML, NJ and parsimony
(bootstrap support, BS). Asterisks (*) indicate a PP<95 or a
BS<50. Prot, protostomians. To simplify the display, several
nodes with a good support (PP>95 and BS80) are marked
by a filled circle; similarly the support for poorly supported
nodes or for a few terminal nodes with average support was
omitted. For the roots of the ‘CavY extended’ and ‘Prot G1’
groups the node support is indicated for two datasets, with
the left-hand column derived from the complete dataset and
the right-hand column derived from a reduced dataset where
the two nematode sequences of the ‘Prot G3’ group were
removed. For the root of the ‘CavY extended’ group the BS
with the NJ analysis was <50 and the support with the
Interior Branch Test is indicated in parentheses; the support
on the left was for a ‘CavY extended’ group including the
two nematode sequences of the ‘Prot G3’ group. The names
of the species are colour-coded as indicated in the top-right
corner of the figure.
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was lost in D. melanogaster (leaving flies without any caveolin)
and many protostomes lack a G2 caveolin.
The high degree of conservation observed among caveolins from
diverse species reveals the same general domain organization,
allowing ready comparison of the roles of particular domains as
well as sequence differences in caveola formation. To begin to
address the question of when the ability to form caveolae arose
during evolution, we examined whether caveola formation can be
induced by caveolins from a number of different vertebrate and
invertebrate species.
The transient expression of HsCav1 causes the de novo formation
of caveolae in Cav1-null mouse embryonic fibroblasts (MEFs) from
Cav1–/– mice (Kirkham et al., 2005). Microinjection of caveolin
cDNAs, together with horseradish peroxidase (HRP) as a marker
for the injected cells, allowed efficient electron microscopy (EM)
analysis of caveola formation using a large number of different
constructs. Cav1-null MEFs injected with cDNA encoding HsCav1
(Fig. 3B) or Canis familiaris Cav1-YFP (CfCav1-YFP) (not shown)
showed similar distribution patterns of Cav1 labelling by light
microscopy and formed surface-connected 65-nm vesicular or
flask-shaped structures that were identical to those in wild-type
MEFs as observed by EM (Fig. 3A). Similar results were obtained
with HsCav1β (data not shown), Mus musculus Cav3-HA
(MmCav3-HA) (Fig. 3C), Danio rerio Cav1-YFP (DrCav1-YFP)
(data not shown) and, interestingly, even with the invertebrate A.
mellifera Cav (AmCav) (Fig. 3D). In stark contrast, nematode
CeCav-a distribution was very uniform across the plasma
membrane, without a clearly identifiable intracellular pool (Fig. 3E).
Most importantly, CeCav-a did not induce the formation of
recognisable caveolae as judged by EM (three independent
experiments; data not shown).
To confirm and extend these studies, we developed a second EM
experimental approach to test specific constructs for their ability to
induce caveolae. This provided an opportunity to examine the
efficiency and morphology of caveola production by different
caveolin constructs at a range of expression levels and to also
examine the effect of expression of flotillin-1 and flotillin-2, at
similar expression levels. Cav1-null MEFs transiently transfected
with GFP constructs were sorted by flow cytometry, based on
fluorescence intensity, into pools of cells with high or low expression
levels. These cells were then processed for EM analysis using
Ruthenium Red to label the plasma membrane (Fig. 4). Clathrin-
coated pits could be visualised in all samples processed and their
density did not vary upon expression of the different constructs
Journal of Cell Science 121 (12)
Fig. 2. Genomic organisation of caveolin genes and a model for the diversification of the caveolin sequences in metazoans. (A) Genomic localisation of caveolin-
encoding genes in four species. Related families are indicated by related colours: Cav1 and Cav3 are pink, Cav2 and Cav2R are green and olive, respectively, and
CavY-related sequences are yellow. When two genes are in a contiguous genomic segment the transcription orientation is indicated by an arrow above each gene.
The symbol ‘//’ between Cav2R and Cav3 in Tetraodon nigroviridis indicates a long genomic segment of ~1.3 Mb. (B) This model is based on the results of the
phylogenetic analysis presented in Fig. 1 and summarises the interpretation in the text. For the parts of the model for which there is no clear phylogenetic support
(represented by dotted lines), the simplest evolutionary model was selected based on the caveolin gene content information in the species studied and the ability of
these sequences to form caveolae structures. For the CavY group, two levels of phylogenetic support are indicated: ‘minimum’ (supported by all the phylogenetic
analysis methods used) and ‘extended’ (supported by two to three of the four methods used).
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tested (data not shown). Caveolae and caveola-like structures were
defined as 50-nm to 70-nm flask-shaped invaginations or smooth
uncoated profiles positive for Ruthenium Red (i.e. surface
connected). Ruthenium-Red-labeled profiles were quantified on
random sections (Fig. 4F; see Materials and Methods). As expected,
CfCav1 and HsCav1β both induced the formation of caveolae (Fig.
4A,C,F). However, in contrast to previous studies (Fujimoto et al.,
2000), no difference was seen in the size, quantity or distribution
of caveolae produced by the two constructs at either high or low
expression levels in this experimental system (Fig. 4F). Furthermore,
no significant induction of caveolae or caveola-like structures was
observed in cells expressing CeCav-a (Fig. 4D,F) or coexpressing
flotillin-1 and flotillin-2 (Fig. 4A,F) as compared with control cells
that express only GFP (Fig. 4B,F). In parallel, the coexpression of
flotillin-1-GFP and flotillin-2-RFP in transfected cells was
confirmed by light microscopy. Interestingly, the transient
coexpression of flotillin-1 and flotillin-2 caused a small but
significant increase in tubular membrane structures (see
supplementary material Fig. S2) morphologically similar to those
implicated in a non-clathrin non-caveolae endocytic pathway
(Kirkham et al., 2005). These structures were morphologically
distinct from caveolae.
Taken together, these results show that in a heterologous
expression system, caveolin from a wide range of species – including
invertebrates – can induce caveola
formation; however, this is not a universal
feature of all caveolins. We found that
caveolae produced during the transient
expression of mammalian Cav1, Cav1β and
Cav3, vertebrate DrCav1 and invertebrate
AmCav all had the same morphology.
Remarkably, insect AmCav could form
caveolae in a mammalian cell despite
differences in membrane temperature, lipid
and/or sterol composition (Marheineke et
al., 1998), and lipid and/or sterol structure
(Rietveld et al., 1999). This highlights the
evolutionary conservation of caveola
formation, even in cells with distinct lipid
composition (Rietveld et al., 1999).
Furthermore, because caveolae-forming
caveolins are found in CavX and possible
CavY descendants, we predict that the
ancestral caveolin was able to form
caveolae.
If functionality is taken into account in
terms of understanding CavX-CavZ
duplication, a parsimonious scenario
would extend the timing of a CavX-CavZ
duplication to before the split between the
protostomes and deuterostomes (Fig. 2).
Then, CavZ would have given rise to
CeCav-a (protostomian G2 group) and the
vertebrate Cav2-Cav2R clade, none of
which form caveolae. But given the
ambiguity in timing the appearance of
CavZ, it is also possible that CeCav-a
and mammalian Cav2 experienced a
convergent loss of function.
These results prompted us to analyse
whether CeCav-a and HsCav1 differed in
other properties. First, we used total internal reflection fluorescence
microscopy (TIRF) to further examine the distribution of CeCav-
a at the plasma membrane of Cav1-null MEFs. Cav1-null MEFs
that express HsCav1-HA clearly exhibited punctate fluorescent
structures (supplementary material Fig. S3). By contrast, CeCav-
a-HA showed a uniform distribution at the plasma membrane,
consistent with the inability of CeCav-a to induce caveola formation
(supplementary material Fig. S3). Second, HsCav1 showed a
polarised distribution in migrating fibroblasts, consistent with
previous work (Sun et al., 2007) but CeCav-a showed a non-
polarised uniform distribution over the cell surface (supplementary
material Fig. S4). Third, HsCav1 inhibited the uptake of the cholera
toxin B subunit when expressed in Cav1-null MEFs, consistent with
previous studies (Kirkham et al., 2005), but CeCav-a had no
detectable inhibitory effect (supplementary material Fig. S3).
Fourth, HsCav1, but not CeCav-a, redistributed to lipid droplets
upon treatment of cells with fatty acids (supplementary material
Fig. S4). Finally, in cells transfected with the constitutively active
form of Rab5 (Rab5Q79L), CeCav-a, but not HsCav1, accumulated
in Rab5Q79L-enlarged endosomes (supplementary material Fig. S4).
This is consistent with infrequent budding of caveolae in
unstimulated cells (Kirkham et al., 2005; Thomsen et al., 2002),
and endocytosis of the non-caveolar CeCav-a via clathrin-coated
pits (Sato et al., 2006). Whether the functional pool of HsCav1 in
Fig. 3. Analysis of the de novo formation of caveolae in mammalian cells. (A) Wild-type MEFs were
labelled with anti-Cav1 (green) and anti-GM130 (red) antibodies and prepared for confocal microscopy or
surface-labelled with CTB-HRP and prepared for electron microscopy. (B-E) Using identical methodology,
Cav1-null MEFs injected with HRP and either HsCav1-HA (B), MmCav3-HA(C) AmCav-HA DNA (D)
and CeCav-a-HA (E) and were prepared for both confocal and electron microscopy. All transiently
expressed constructs, except CeCav-a-HA had the same subcellular distribution as Cav1 in wild-type MEFs
as determined by confocal microscopy and produced surface-connected caveolae as identified with electron
microscopy. Injected cells were identified by electron-dense HRP-DAB labelling of the nucleus. Scale
bars: 10 μm (confocal images), 200 nm (EM images).Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
2080
all these assays is within caveolae is not clear but, taken together,
these results suggest that, caveolins that do not drive caveolae
formation have distinct properties and, presumably, at least some
distinct functions.
Molecular dissection of caveola formation
To gain insights into formation of caveolae, we examined the
importance of posttranslational modifications of caveolins or the
effect of previously described mutants of caveolins – many of which
have been associated with disease – on caveola formation in Cav1-
null MEFs using the assays described above (see Fig. 3). The results
are summarised in Figs 5 and 6. A triple point mutant of CfCav
(CfCav1-HACYS–) that cannot be palmitoylated, was localised to
the plasma membrane using confocal microscopy and formed
caveolae identical to those found in wild-type MEFs – as judged
by EM (supplementary material Fig. S5). Mammalian Cav1 is
phosphorylated at Y14 and S80. The Y14 residue can be deleted
without affecting caveolae formation because both HsCav1β (Fig.
4)and CfCav1Δ3-48 (Fig. 5A) can generate caveolae; although, if
Y14 is present it may have a regulatory role on caveola formation
(Orlichenko et al., 2006). We also analysed Cav1-null MEFs that
express the non-phosphorylatable point mutant HsCav1S80A. The
HsCav1S80A mutant protein was localised to the plasma membrane
Journal of Cell Science 121 (12)
Fig. 4. Quantification of the de novo formation of caveolae in mammalian
cells. (A-F) Cav1-null MEFs transiently transfected with CfCav1-YFP (A,F),
GFP (B,F), HsCav1β-GFP (C,F) CeCav-a-GFP (D,F), HCav49-132-GFP (F) or
co-transfected with flotillin1-GFP and flotillin2-RFP (E,F), were FAC sorted
by fluorescent intensity into two pools with different expression levels with the
exception of flotillin-1 and flotillin-2. The cells were fixed and examined by
electron microscopy. Caveolae (arrows) were only observed in cells
transfected with CfCav1-GFP, HsCav1β-GFP and at a lower frequency in cells
expressing HCav49-132-GFP. Clathrin-coated pits are highlighted by
arrowheads. Scale bars: 200 nm. (F) Caveolae-like structures as determined by
morphology were counted at the plasma membrane and the density of
caveolae-like structures was determined. **P0.05, difference between high
and low expression pools of the same construct.
Fig. 5. Summary of the 33 different caveolin constructs analysed. (A) EM
micrographs of Cav1-null MEFs microinjected with HRP and either HsCav-
HAΔ3-48, MmCav3-HAΔ1-16, CfCav1-HAΔ147-178 or HCav-HA49-132 DNA. The
cell surface was labelled with CTB-HRP. All the constructs generated caveolae
that were similar to endogenous caveolae in wild-type MEFs. Scale bars: 200
nm. (B) Schematic protein alignment illustrating the protein-domain structure
and some of the known post translational modifications of HsCav1, HsCav3
and CeCav-a. The scale bar indicates the number of amino acids from the start
of the N-terminus of CeCav-a. Pink circles highlight palmitoylated residues,
yellow circles mark some of the residues mutated in HsCav3 in muscle
diseases. Circles with broken lines and lightly shaded mark non-conserved
residues. (C) Summary of the results of EM and light-microscopy experiments
from the constructs tested in this study. #, constructs that formed caveolae but
were less efficient than wild-type constructs. ^ , 20% of cells expressing this
construct contained more peripheral structures, but these were judged not to be
caveolae by light microscopic methods.
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
2081Biogenesis of caveolae
and capable of forming caveolae, as determined
by the EM caveola-biogenesis assay
(supplementary material Fig. S5). By contrast,
HsCav1S80E, which mimics chronic
phosphorylation of this residue, was localised
almost exclusively to the Golgi complex
(supplementary material Fig. S5). Therefore,
phosphorylation of HsCav1S80 is not required for
caveola formation, but it may regulate caveolin
and/or caveolae trafficking to or from the plasma
membrane. Other mutants of Cav3 implicated in
muscular dystrophy were either retained in the
Golgi complex (MmCav3P104L) or generated
apparently normal caveolae (MmCav3C71W) (data
summarised in Fig. 5).
Analysis of the C-terminus and the
intramembrane domain of caveolins in the
formation of caveola 
To gain more insights into the requirements for
caveola formation, we took advantage of the fact
that CeCav-a efficiently traffics to the plasma
membrane and used CeCav-a as a backbone to
introduce mammalian caveolin domains that may
facilitate the formation of caveola. We first
focused on the C-terminal half of caveolin, where
the last 31 amino acids can be deleted without
affecting caveolae formation (summarised in Figs
5, 6, and supplementary material Fig. S5). In
addition, CfCav1Δ147-178 showed reduced plasma
membrane localisation as compared with HsCav1-
HA and CfCav1Δ157-178. Notably, a progressive
reduction in caveolin oligomerisation, and plasma
membrane localisation that was proportional to the
severity of the deletion, has been reported earlier
(Ren et al., 2004).
Next, we analysed the hybrid protein HCav-
HA1-132, where the amino acid residues 1-132 of
the hybrid protein originate from residues 1-132
of HsCav1 and the remaining C-terminal amino
acids are from CeCav-a (schematic of Hybrid: Fig.
6). All hybrid mutants are named after the segment
originating from HsCav1. HCav-HA1-132 formed
caveolae that were morphologically similar to
HsCav1 (data not shown), clearly indicating that
the C-termini of HsCav1 and CeCav-a, in
particular amino acids 132 to 147, are functionally
equivalent. The C-terminus of mammalian Cav2
has been previously shown to support caveola
biogenesis when present in a hybrid protein with
mammalian Cav1 (Breuza et al., 2002). Closer inspection of all
mammalian Cav1, Cav2, Cav3 and CeCav-a C-termini (Fig. 6,
supplementary material Fig. S1) highlights several conserved amino
acid residues, such as P132 and K135. Furthermore, mammalian
Cav1, Cav2 and Cav3 contain a series of four hydrophobic residues
in an n+3 spacing, which comprises leucines, isoleucines and valines
that are partly conserved in CeCav-a (Fig. 6). The importance of
this region has further been highlighted by the fact that four out of
six newly identified mutations in human breast cancer are located
between amino acid residues P132 and Y148 in HsCav1 (Fig. 6)
(Li et al., 2006).
Finally, we created the hybrid protein HCav1-102 that containes
only the N-terminal region from HsCav1(1-102). This construct did
not induce caveola formation, as demonstrated through a range of
EM and light-microscopy assays, but did reach the plasma
membrane in a small subset of cells (supplementary material Figs
S5, S6). Hence, the intramembrane domain of CeCav1 cannot
substitute for the intramembrane domain of HsCav1, while the C-
termini have equivalent function.
It is interesting to note that the intramembrane domains of CeCav-
a and mammalian Cav1 are highly conserved, comprising mostly
conservative amino acid substitutions (supplementary material Fig.
Fig. 6. Analysis of caveola formation using deletion mutants and hybrid proteins. (A) Topology
model of caveolin. Orange boxes mark the region of interest that are shown in alignments below.
(B) Sequence alignment. Dark grey, identical residues; light grey, similar residues; purple, partly
conserved hydrophobic residues; red asterisks, residues mutated in breast cancer; shaded yellow
region, residues that can be deleted without affecting caveola formation; red line and red text,
residues that are not conserved in CeCav-a compared with all other sequences in the alignment;
black asterisks, residues implicated in muscular dystrophy when mutated in HsCav3. (C) Caveolin
mutants used in this study. Grey, N- and C-terminal regions; dark blue, oligomerisation domain;
light blue, scaffolding domain; red, intramembrane domain. Curved lines indicate missing
sections. Regions highlighted in green are from CeCav-a. Orange, regions of interest that are
shown in alignments. + and – presence and absence, respectively, of caveolae according to the
results of the EM caveola biogenesis assay. Scale bars indicate the number of amino acids.
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S1) – with three notable exceptions. These involve residues S104,
F124 and A129, which in CeCav-a are replaced by a valine, serine
and isoleucine, respectively. Each residue is completely conserved
in vertebrate Cav1 (supplementary material Fig. S1), and each of
these changes causes a dramatic change in side-chain hydrophobicity
(S/V, 0.46 to –0.46; F/S, –1.71 to 0.46; A/I, 0.50 to –1.12) as
determined by Wimley and White (Wimley and White, 1996).
Intriguingly, a microdeletion of F124 is known to cause muscular
dystrophy (Cagliani et al., 2003) and, of those residues, F124 is the
only one conserved in AmCav but not CeCav-a (supplementary
material Fig. S1).
Role of the N-terminus of caveolin in caveola formation
To analyse a potential role of the N-terminus in caveola formation,
we examined a series of N-terminal truncation mutants of
mammalian Cav1 and Cav3. The first 48 amino acids of CfCav1
or the equivalent region of MmCav3 can be deleted without
affecting its ability to form caveolae (summarised in Figs 5, 6).
Next, we created further hybrid proteins between HsCav1 and
CeCav-a with increasing proportions of the N-terminal region of
CeCav-a replacing corresponding regions of HsCav1. CeCav-a
possesses a unique N-terminal extension that is missing in
mammalian isoforms. First, we determined through a series of
deletion mutants and hybrid proteins that this N-terminal extension
did not inhibit caveolae formation (supplementary material Fig. S5).
Of all the hybrid proteins designed specifically to analyse the N-
terminal region (summarised in Figs 5, 6), only HCav49-132 (HsCav1
amino acid residues 49-132) was capable of forming caveolae (Figs
4-6). Examination of transfected cells using confocal microscopy
showed some regions of the plasma membrane with a diffuse surface
distribution of HCav49-132 (supplementary material Fig. S5). To
investigate this further, we quantified the caveolae produced by
HCav49-132 by using the quantitative EM assay described in Fig. 4.
HCav49-132 did not produce caveolae with an abnormal morphology
but produced caveolae less efficiently. At the lower expression level
HCav49-132 was far less efficient than wild-type caveolin in
generating caveolae. Importantly, HCav60-132 that contained only
11 more amino acids from CeCav-a, failed to form caveolae as
determined by both the EM biogenesis assay (data not shown) and
TIRF microscopy (supplementary material Fig. S6). These results
confirm the importance of amino acids 48-60 in caveola formation.
The region 46-55 has recently been implicated in localising caveolin
correctly in migrating fibroblasts (Sun et al., 2007).
Based on our sequence alignments this region can be confined
further. As residues 50-55 of HsCav1 are identical between
vertebrate Cav1 and CeCav-a, the first crucial amino acid for
HsCav1 is likely to reside between residues 56 and 59
(supplementary material Fig. S1). This region contains the residue
equivalent to the Cav3 muscular dystrophy mutant Cav3P28A (Betz
et al., 2001). Intriguingly, this phenylalanine is conserved in AmCav
but substituted by an alanine residue in CeCav-a (marked in red in
Fig. 6B). Other signature residues that distinguish the caveola-
forming sequences from those that do not form caveolae include
G77, C133 and S149. Although C133 and S149 are either outside
the regions required for caveola formation or can be mutated without
inhibiting formation of caveola, these residues might still facilitate
efficient caveola formation in vivo.
Finally, we asked whether caveola formation is dependent on the
interaction of the hybrid Cav proteins with Cav2. In Cav1-null MEFs
endogenous MmCav2 is localised to the Golgi complex but
redistributes to the plasma membrane upon transient overexpression
of HsCav1 (supplementary material Fig. S6) (Mora et al., 1999).
We therefore analysed our HCav hybrid mutants for the loss of Golgi-
complex-localised MmCav2. Surprisingly, all hybrid proteins were
capable of interacting with MmCav2, independently of their ability
to form caveolae (supplementary material Fig. S5). Thus the specific
interaction with Cav2 is not an indicator of caveola formation.
Discussion
In this study we have carried out a detailed phylogenetic analysis
of caveolins. In addition, we analysed the ability of caveolins from
different species, as well as mutant forms of caveolin, to cause the
de novo formation of caveolae in mammalian cells. We have shown
that, although caveolins are conserved in evolution, their ability to
cause formation of caveolae in this model system is not. Whereas
many mutants of mammalian caveolins accumulate in the Golgi
complex, we have shown that C. elegans caveolin reaches the
plasma membrane but does not form caveolae. This finding allowed
us to generate hybrid proteins by using C. elegans caveolin as a
scaffold and to generate a new model of caveola formation.
Surprisingly, we found that coexpression of flotillin-1 and flotillin-
2 did not cause the formation of caveola-like structures in our
experimental system. Previous studies showed an increase in
caveola-like invaginations on expression of flotillin-1 and flotillin-
2 (Frick et al., 2007). In contrast to those studies, the experiments
described here were performed in cells that lack caveolae and Cav1.
We conclude that within cells that lack Cav1 either flotillin-1 and
flotillin-2 cannot induce caveola-like structures, or these structures
are very dynamic once formed and are quickly endocytosed. It is
interesting to note that the coexpression of flotillin-1 and flotillin-
2 caused an increase in tubular structures (supplementary material
Fig. S2) with similar morphology to clathrin-independent endocytic
carriers (CLICs) (Kirkham et al., 2005). This pathway is regulated
by flotillin-1 (Glebov et al., 2006) but further work will be required
to dissect the precise role of flotillin-1 in CLIC formation and/or
dynamics.
A systematic phylogenetic analysis of caveolin sequences
indicates that caveolins in vertebrates originate from three ancestral
genes: CavX, CavZ and CavY (Fig. 2B). Using a mammalian-cell-
based assay to study the de novo formation of caveolae, we found
that both descendants of CavX (mammalian Cav1 and Cav3,
vertebrate DrCav1) and CavY descendants (invertebrate AmCav)
formed morphologically similar caveolae. This highlights the
evolutionary conservation of caveola formation and indicates that
the CavY-CavX ancestral caveolin was able to form caveolae.
However, there is not uniform conservation of caveolin formation
in the animal lineage. In contrast to the caveola-forming AmCav
from A. mellifera, another invertebrate caveolin – CeCav-a from
C. elegans – does not form caveolae.
We then extended the study to gain insights into how caveolin
forms caveolae. The analysis of chimeric caveolins and mutants
based on sequence comparison of caveolins with differential ability
to form caveolae revealed that residues 49-147 in mammalian Cav1
are required for caveola formation. No wild-type caveolin construct
(from mammals to invertebrates) and no mutant caveolin formed
caveolae of abnormal morphology, as judged by conventional EM.
Rather than producing abnormal caveolae, a reduction in the
efficiency of caveola formation was observed. Thus, caveola
formation seems to be a binary event, i.e. all or nothing. This
included caveolae produced by expression of MmCav3C71W,
equivalent to a possible polymorphism originally implicated in
muscular dystrophy (de Paula et al., 2001; McNally et al., 1998;
Journal of Cell Science 121 (12)
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Vatta et al., 2006), which – when expressed in fibroblasts – inhibits
specific cholesterol-dependent signalling pathways (Carozzi et al.,
2002).
We provide evidence that caveolin genes underwent extensive
and ancient local and genomic gene duplication to produce diversity
in caveolin function. We have analysed information on the genomic
organisation of caveolin genes and combined this with the
phylogenetic analysis to suggest a model for the ancient evolution
of the three main groupings of caveolins: CavX, CavY and CavZ
(Fig. 2B). The precise timing of the two duplications that gave rise
to these three groupings is unclear, although at least one duplication
took place before the split between vertebrates and urochordates,
and both possibly occurred even before the split between
protostomes and deuterostomes (Fig. 2B). There is also evidence
for other genomic gene duplication and loss in the caveolin gene
family. It would seem that, during vertebrate speciation, a genetic
segment containing ancestral CavX and CavY duplicated to give
rise to Cav1 and Cav2, and Cav3 and Cav2R with subsequent loss
of Cav2R in placental mammals. Also, in most vertebrates except
amphibians, it appears the CavY descendant was lost. Furthermore,
there are numerous duplicates of caveolin genes in non-vertebrate
species that are more closely related to each other than to caveolins
of other species (Fig. 1).
This caveolin gene plasticity is in dramatic contrast to the very
limited diversification of clathrin heavy and light chain genes,
which also encode proteins involved in membrane-coat formation.
The genes for clathrin subunits are present in all eukaryotic
lineages, whereas caveolins are limited to metazoans (Field et al.,
2007). In the animal kingdom there is only one gene that encodes
clathrin heavy chain and one that encodes clathrin light chain in
non-vertebrate species, and there is evidence for only limited
duplication in the vertebrate lineage (Wakeham et al., 2005). The
more recent emergence and greater variability of caveolin genes
may reflect considerably more flexibility in function for caveolins
than for clathrin. Although caveolins and their ability to form
caveolae are evolutionarily conserved, it appears that there has been
also a conserved divergence of function in the caveolin family. In
C. elegans, and in the Cav2-Cav2R lineage of vertebrates, the
ability of caveolin to form caveolae is lost. Genes encoding
caveolins that do not form caveolae arose from an ancient
duplication in the metazoan lineage (Fig. 2). The fact that they
survived selection and have been retained, strongly suggests they
have a function.
CeCav-a behaved differently to mammalian caveolin in a wide
range of cellular processes including the redistribution to de-novo-
formed lipid droplets, the relocation to the rear of migrating
fibroblasts, and the failure to cause an inhibition of clathrin-
independent endocytosis. In addition, CeCav-a but not HsCav1
accumulated within enlarged early endosomes when expressed
with a dominant-active Rab5 mutant. This observation suggested
that incorporation of caveolins into caveolae results in their
retention at the surface, preventing internalisation, or allows their
rapid recycling so that those caveolins that do not form caveolae
have a less-restricted localization in the endocytic pathway.
Internalisation of non-caveolar CeCav-a is consistent with in vivo
studies in the C. elegans embryo where CeCav-a has been
demonstrated to be internalised via a clathrin-dependent process
(Sato et al., 2006). Intriguingly, a recent report has indicated that
CeCav-a has some functional similarities to mammalian caveolins
at the neural muscle junction (Parker et al., 2007). Whether this
involves caveolae is not yet known but it is important to note that,
even in mammalian cells, there is increasing evidence for non-
caveolar functions of caveolins (Head et al., 2007; Hill et al., 2008;
Parton and Simons, 2007).
The role of caveolin in caveola formation – a model
By combining the increased understanding of caveolin evolution
with the molecular analysis of an array of caveolin constructs we
were able to refine a model of caveolae formation. On the basis of
a variety of secondary structure and hydrophobicity prediction
algorithms, we previously presented a topology model for MmCav1
(Parton et al., 2006), which can now be significantly refined (Fig.
6). The model predicted caveolin-caused membrane curvature
through the insertion into one membrane leaflet of an amphipathic
α-helices (MmCav1 resides 80-95) and the interaction of cholesterol
with the intramembrane domain of caveolin, such that the helix acts
like a wedge, displacing lipids in the inner but not the outer
membrane leaflet, and thus create membrane curvature (McMahon
and Gallop, 2005). At the time it was possible that the extreme N-
and C-termini were necessary to stabilise the overall protein
conformation. Regarding the complete dispensability for caveola
formation of segments 1-49 and 157-178 in HsCav1, we can now
rule out such a requirement. An alternative, based on the requirement
of segment 49-60 for caveola formation, could be that this segment
has a stabilizing function for the in-plane α-helix (Parton et al.,
2006; Spisni et al., 2005) (Fig. 6). It is likely to be influenced by
phosphorylation of S80, which should result in a relocation of this
helix into the membrane interface region. Such a scenario is
supported by the fact that HsCav1S80A has an increased affinity for
cholesterol (Fielding et al., 2004) and our observation that
HsCav1S80A but not HsCav1S80E is capable of caveola formation
(Fig. 4). These findings highlight a potential regulatory role of this
highly conserved residue in caveolae formation and function and
possibly also caveolae disassembly.
Additional elements that may help to stabilise caveolin in
caveolae might also be present in the C-terminus. The segment 132-
147 contains a series of four hydrophobic residues in an n+3 spacing
comprising leucines, isoleucines, and valines (Fig. 6B) that may
insert into the membrane or alternatively, be involved in caveolin
oligomerisation. The slight loss in plasma membrane localisation
of CfCav1147-178 but not CfCav1157-178 might be the result of cutting
into this structure. It has been reported that the severity of the
deletion of the C-terminus is proportional to the reduction in
caveolin oligomerisation and plasma membrane localization (Ren
et al., 2004). Thus the increasing removal of functional residues
that could help to stabilise the C-terminal region might lead to a
progressive reduction in the efficiency of caveolae production,
although the loss of any one such element, e.g. palmitoylation, is
dispensable.
With respect to the intramembrane domain, our model places
residue F124 within the intramembrane domain at the same
penetration depth as the segment 97-YWFY-100, which forms part
of the CRAC motif and is believed to be involved in cholesterol
binding (Li and Papadopoulos, 1998; Parton et al., 2006). F124 was
conserved in caveola-forming caveolin and interaction of these
residues might be necessary for a stable interaction between inward
and outward helices of the intramembrane domain. Bulky residues
between these two helices close to the membrane interface,
combined with a tight turn of residues 108-GIPM-111 in the
hydrocarbon core, might result in a cone-shaped intramembrane
domain. Although we previously assumed that the intramembrane
domain increases the volume of both membrane leaflets equally
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
2084
(Parton et al., 2006), this might contribute further to the creation
of membrane curvature.
We propose that caveolin causes membrane deformation of the
cytoplasmic leaflet through a combination of amphipathic helix
insertion and interaction with cholesterol. The membrane
deformation is then stabilised and concentrated through
oligomerisation of caveolin and the interaction with cholesterol.
These steps, fundamental for caveola formation, are mediated by
different regions of caveolin. This would explain the wide range
of caveolin mutations that affect caveola formation. This model does
not preclude the involvement of other proteins or lipids in regulating
caveola formation. In fact, recent studies suggest that other proteins
can regulate caveolae stability or formation driven by caveolin (Hill
et al., 2008; Pelkmans and Zerial, 2005). These studies provide a
framework for understanding the mechanics of membrane
morphogenesis by caveolins, the regulation of this process in vivo,
and provide fundamental new insights into the evolution of caveolae
and caveolins.
Materials and Methods
Cell culture and cell treatments
BHK cells were grown in DME (Invitrogen, Carlsbad, CA) supplemented with 10%
(v/v) heat-inactivated Serum Supreme (Cambrex Bio Science, Australia) and 2 mM
L-glutamine (Invitrogen). Primary cultures of MEFs were isolated and cultured as
described previously (Kirkham et al., 2005). Lipid-based transfection of cells were
performed using Lipofectamine 2000 (Invitrogen) according to manufacturer’s
instructions. Oleic acid treatment was performed as previously described (Pol et al.,
2004). The uptake and measurement of CTB conjugated to Alexa Fluor 594
(Invitrogen) within the Golgi complex was performed as described previously
(Kirkham et al., 2005).
Antibodies and reagents
Antibodies were obtained from the following sources: rabbit anti-caveolin, mouse
anti-GM130 and mouse anti-Cav2 (BD Biosciences, San Jose CA), rabbit anti-HA
(provided by T. Nilsson, Gothenburg University, Sweden), mouse anti-HA (16B12)
(BabCO, Richmond, CA), mouse anti-Flag and rabbit anti-Flag (Sigma-Aldrich).
Secondary antibodies conjugated to Alexa Fluor 488 and 660 (Invitrogen) and to
CY3 (Jackson ImmunoResearch Laboratories, West Grove, PA). An extensive
summary of the DNA constructs used in this study is contained in a Table S2 in
supplementary material. Constructs created for this study were generated by primer-
extension PCR (primer sequences can be given by request) or are described in previous
studies (Carozzi et al., 2002; Fielding et al., 2004; Luetterforst et al., 1999; Ren et
al., 2004; Scheel et al., 1999; Stenmark et al., 1994; Way and Parton, 1996). All new
constructs generated were sequenced (AGRF, Brisbane, Australia).
EM caveola biogenesis assay
Primary cell cultures of Cav1-null and wild-type MEFs were microinjected as
previously described (Kirkham et al., 2005) with 10 mg/ml HRP in the injection mix.
All the cells in a defined area, roughly five to ten cells across and 15-30 cells down,
were microinjected and allowed to recover in normal growth medium for 12-15 hours
at 37°C in 5% CO2. The plasma membrane of injected cells was labelled on ice with
10 μg/ml CTB-HRP (Invitrogen) as previous described (Kirkham et al., 2005). The
cells were processed for DAB visualisation and resin embedding using standard
protocols (Kirkham et al., 2005) with the following modification. Injected cells with
DAB reaction product in the nucleus were relocated after embedding by making marks
in the plastic dish after the DAB reaction. The marked area was then identified and
the cells were cut parallel to the culture substratum. In parallel cells grown on a glass
coverslip were injected using the same injection mix and the protein expression level
was determined by immunofluorescent confocal analysis.
Cells with HRP-positive nuclei were analysed by electron microscopy for CTB-
HRP-positive structures and were compared with neighbouring non-injected cells. A
negative results were adjudged by no noticeable different between injected and non-
injected cells in the morphology and distribution of CTB-HRP positive structure.
Positive results were adjudged by the appearance of 50-nm to 70-nm flask-shaped
invaginations or smooth uncoated vesicles in different planes.
Flow cytometry and EM analysis
Cav1–/– immortalised MEFs were transfected using Lipofectamine LTX was used
with PLUS reagent (Invitrogen) overnight with various GFP-tagged caveolin
constructs, or co-transfected with flotillin-1-GFP and flotillin-2-RFP at a ratio of 1:3,
so that all cells expressing flotillin-1-GFP expressed flotillin-2-RFP (as tested in
parallel using light microscopy). Cells were trypsinised the next day, and the cell
suspension was sorted by GFP fluorescence using a Influx Cell Sorter (Cytopeia).
The GFP-positive population was sorted into two wells of a 24-well plate based on
the intensity of GFP. Roughly 10% of cells were sorted into high-GFP or low-GFP
wells for all the caveolin constructs, giving a ~20% transfection rate. Note that only
low-GFP expressors were obtained for flotillin-1 and flotillin-2. Cells were sorted
into growth medium containing penicillin-streptomycin, and placed in 5% CO2
incubator for 4 hours. Unattached cells were washed off, and fresh medium with
penicillin-streptomycin was added for a further 3-hour incubation prior to fixation
in 2.5% glutaldehyde containing 1 mg/ml Ruthenium Red for 1 hour at RT.
Labelling of the cell surface by Ruthenium Red and Epon resin embedding was
performed as previously described (Parton et al., 2002). Quantification of surface-
connected structures was performed on over 500 μm of plasma-membrane profile
for each condition. A 1000-nm square grid was superimposed over the electron
micrograph and the cell perimeter calculated based on the number of intersections
with the grid lattice. All Ruthenium Red-positive structures were tallied per cell.
Total number of caveolae or caveolae-like structures were divided by the calculated
cell perimeter and multiplied by 100 to give caveolae per 100 μm plasma-membrane
profile.
Immunofluorescence microscopy
Cells were fixed and prepared for immunofluorescence microscopy as previously
described (Kirkham et al., 2005) with only minor modifications. Cells visualised by
TIRF microscopy were mounted in PBS-containing 0.5% n-propyl gallate, all other
samples were mounted in Aqua-polymount (Polysciences Inc., Warrington, PA). Lipid
droplets were visualised as previously described (Martin et al., 2005). Confocal
immunofluorescence microscopy was performed using a Zeiss LSM 510 meta confocal
microscope. Images were processed using Zeiss confocal microscopy software version
3.2 and Adobe Photoshop version 7, and figures were compiled using Adobe Illustrator
version 10 and Microsoft Powerpoint X. TIRF microscopy was performed using an
Olympus X81 inverted microscopy adapted for TIRF microscopy (by Olympus),
Images were processed and analysed using Metamorph software.
Dataset and phylogenetic analysis
To constitute the caveolin dataset an initial BLAST (Altschul et al., 1990) search was
performed to screen NCBI’s non-redundant database and all the caveolin and caveolin-
like sequences gathered. Additional sequences were obtained by screening NCBI’s
Expressed Sequence Tags (EST) database by BLAST searches. The following genome
assemblies were also screened: Branchiostoma floridae, Capitella sp., Ciona
intestinalis, Daphnia pulex, Helobdella robusta, Lottia gigantea, Monosiga brevicollis,
Nematostella vectensis, Trichoplax adhaerens and Xenopus tropicalis (DOE JGI,
http://genome.jgi-psf.org); Ciona intestinalis, Ciona savignyi, Gasterosteus aculeatus,
Oryzias latipes and Takifugu rubripes (Ensembl, http://www.ensembl.org/index.html),
Strongylocentrotus purpuratus (UCSC, http://genome.ucsc.edu), Caenorhabditis
genomes (Wormbase, http://www.wormbase.org) and the insect genomes of Flybase
(http://flybase.bio.indiana.edu/). For the EST and genomic searches, many query
sequences from the different caveolin groups were used. Since most of the caveolin
duplications preceded the emergence of vertebrates, the sequence search strategy was
limited in mammals and particularly targeted the non-vertebrate metazoans to resolve
this pattern of duplication. For the final dataset, all the partial sequences were discarded
and to speed up the calculations, a maximum of five placental mammal sequences
were kept for each group of caveolin.
Genomic localizations of caveolin genes were determined using the UCSC genome
browser (Karolchik et al., 2003) BLAT search or BLAST searches of genome
assemblies at Ensembl, JGI or Wormbase websites. The sequence alignment is in
supplementary material Fig. S1 and the accession numbers and genomic localization
in supplementary material Table S1.
The amino acid sequences from the 118 caveolins composing the final dataset
were aligned using MAFFT (Katoh et al., 2002). Phylogenetic analyses were
performed with four methods: Bayesian interference, maximum-likelihood, neighbour-
joining (NJ) and parsimony. Parsimony analyses were conducted with PAUP*4.0b10
(Swofford, 2003), using the tree bisection-reconnection branch swapping algorithm,
heuristic searches and 500 replicates. NJ analyses were performed with MEGA3.1
(Kumar et al., 2004) using a poisson correction distance with 500 replicates; to define
groups we also use the interior branch test (Sitnikova, 1996). For the Bayesian
interference and ML analyses the best-fitting model of protein sequence evolution
was selected by PROTTEST1.4 (Abascal et al., 2005) using the Akaike Information
Criterion; the model selected was the JTT+Γ+I model (WAG+Γ+I+F when the
observed amino acid frequencies were considered). ML analyses were performed
with PHYML2.4.4 (Guindon and Gascuel, 2003) with the JTT+Γ+I model and 500
replicates. Bayesian analyses were performed using MRBAYES3.1.2 (Ronquist and
Huelsenbeck, 2003) and the GTR+Γ+I+F model. Sampling was performed with one
cold chain and three heated chains, which were run for 1,000,000 generations. Three
independent runs were performed and the trees were sampled every 200th generation.
Graphical inspection of the runs was then performed to determine the length of the
‘burnin’ stage; in all three runs the first 2500 trees were discarded before a consensus
tree was generated.
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